Cite
Doxorubicin enhances oxysterol levels resulting in a LXR-mediated upregulation of cardiac cholesterol transporters.
MLA
Monzel, Judith V., et al. “Doxorubicin Enhances Oxysterol Levels Resulting in a LXR-Mediated Upregulation of Cardiac Cholesterol Transporters.” Biochemical Pharmacology, vol. 144, Nov. 2017, pp. 108–19. EBSCOhost, https://doi.org/10.1016/j.bcp.2017.08.008.
APA
Monzel, J. V., Budde, T., Meyer zu Schwabedissen, H. E., Schwebe, M., Bien-Möller, S., Lütjohann, D., Kroemer, H. K., Jedlitschky, G., & Grube, M. (2017). Doxorubicin enhances oxysterol levels resulting in a LXR-mediated upregulation of cardiac cholesterol transporters. Biochemical Pharmacology, 144, 108–119. https://doi.org/10.1016/j.bcp.2017.08.008
Chicago
Monzel, Judith V., Thomas Budde, Henriette E. Meyer zu Schwabedissen, Matthias Schwebe, Sandra Bien-Möller, Dieter Lütjohann, Heyo K. Kroemer, Gabriele Jedlitschky, and Markus Grube. 2017. “Doxorubicin Enhances Oxysterol Levels Resulting in a LXR-Mediated Upregulation of Cardiac Cholesterol Transporters.” Biochemical Pharmacology 144 (November): 108–19. doi:10.1016/j.bcp.2017.08.008.